{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:22:27Z","timestamp":1787440947822,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2023.17955"],"award-info":[{"award-number":["2023.17955"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2024.16701"],"award-info":[{"award-number":["2024.16701"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2023.13291"],"award-info":[{"award-number":["2023.13291"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["RISE-Health \\u2013 UID\/06397\/2025"],"award-info":[{"award-number":["RISE-Health \\u2013 UID\/06397\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Conseller\u00eda de Cultura, Educaci\u00f3n e Ordenaci\u00f3n Universitaria, Xunta de Galicia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010801","name":"Xunta de Galicia","doi-asserted-by":"publisher","award":["ED481B-2023-092"],"award-info":[{"award-number":["ED481B-2023-092"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["CEECIND\/CP1655\/CT000"],"award-info":[{"award-number":["CEECIND\/CP1655\/CT000"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["04016"],"award-info":[{"award-number":["04016"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119536","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T13:00:25Z","timestamp":1779454825000},"page":"119536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson\u2019s disease"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-5797","authenticated-orcid":false,"given":"Cl\u00e1udia Sofia","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8649-941X","authenticated-orcid":false,"given":"Joana","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Rita","family":"Alfenim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius","family":"de Monte Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"D\u00edaz-Tom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Otero Espinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-0703","authenticated-orcid":false,"given":"Carlos","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2026.119536_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/pharmaceutics16060708","article-title":"Drug development for Alzheimer\u2019s and Parkinson\u2019s disease: where do we go now?","volume":"16","author":"Sequeira","year":"2024","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119536_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030350","article-title":"Lipidic nanoparticles, extracellular vesicles and hybrid platforms as advanced medicinal products: future therapeutic prospects for neurodegenerative diseases","volume":"16","author":"Tsakiri","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119536_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101658","article-title":"Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform","volume":"79","author":"Pinto","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2026.119536_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.143245","article-title":"ROS-responsive hierarchical targeting vehicle-free nanodrugs for three-pronged Parkinson\u2019s disease therapy","volume":"466","author":"Fan","year":"2023","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119536_bib5","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acsptsci.4c00124","article-title":"Cellular and mitochondrial toxicity of tolcapone, entacapone, and new nitrocatechol derivatives","volume":"7","author":"Pinto","year":"2024","journal-title":"ACS Pharm. Transl. Sci."},{"issue":"43","key":"10.1016\/j.biopha.2026.119536_bib6","doi-asserted-by":"crossref","first-page":"58299","DOI":"10.1021\/acsami.4c12372","article-title":"Exploring nanocarriers for boosting entacapone bioavailability: a journey through system characterization and assessment of toxicity and pharmacological and 2D permeability paybacks","volume":"16","author":"Machado","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119536_bib7","doi-asserted-by":"crossref","DOI":"10.1021\/acsami.4c12372","article-title":"Exploring nanocarriers for boosting entacapone bioavailability: a journey through system characterization and assessment of toxicity and pharmacological and 2D permeability paybacks","author":"Machado","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119536_bib8","doi-asserted-by":"crossref","unstructured":"Gartziandia O Fau - Herr\u00e1n, E.; Herr\u00e1n E Fau - Ruiz-Ortega, J.A.; Ruiz-Ortega Ja Fau - Miguelez, C.; Miguelez C Fau - Igartua, M.; Igartua M Fau - Lafuente, J.V.; Lafuente Jv Fau - Pedraz, J.L.; Pedraz Jl Fau - Ugedo, L.; Ugedo L Fau - Hern\u00e1ndez, R.M.; Hern\u00e1ndez, R.M. Intranasal Administration of chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease. 2016, (1550-7033 (Print)). DOI: 10.1166\/jbn.2016.2313 From 2016 Dec.","DOI":"10.1166\/jbn.2016.2313"},{"issue":"1","key":"10.1016\/j.biopha.2026.119536_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010058","article-title":"Intranasal drug delivery by nanotechnology: advances in and challenges for Alzheimer's disease management","volume":"16","author":"Dighe","year":"2023","journal-title":"Pharmaceutics"},{"issue":"21","key":"10.1016\/j.biopha.2026.119536_bib10","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1039\/D4TB00521J","article-title":"Lipid-polymer hybrid nanoparticles loaded with N-acetylcysteine for the modulation of neuroinflammatory biomarkers in human iPSC-derived PSEN2 (N141I) astrocytes as a model of Alzheimer's disease","volume":"12","author":"Vargas-Barona","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.biopha.2026.119536_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030329","article-title":"Navigating the nose-to-brain route: a systematic review on lipid-based nanocarriers for central nervous system disorders","volume":"16","author":"Agosti","year":"2024","journal-title":"Pharmaceutics"},{"issue":"43","key":"10.1016\/j.biopha.2026.119536_bib12","doi-asserted-by":"crossref","first-page":"58299","DOI":"10.1021\/acsami.4c12372","article-title":"Exploring nanocarriers for boosting entacapone bioavailability: a journey through system characterization and assessment of toxicity and pharmacological and 2D permeability paybacks","volume":"16","author":"Machado","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.biopha.2026.119536_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2026.119536_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2183830","article-title":"Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs","volume":"30","author":"Tang","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119536_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.colsurfa.2011.10.012","article-title":"Surface modification of poly(lactide-co-glycolide) nanoparticles by d-\u03b1-tocopheryl polyethylene glycol 1000 succinate as potential carrier for the delivery of drugs to the brain","volume":"392","author":"Jalali","year":"2011","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.biopha.2026.119536_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4274\/tjps.galenos.2021.37998","article-title":"A combination of virgin coconut oil and extra virgin olive oil elicits superior protection against doxorubicin cardiotoxicity in rats","volume":"19","author":"Utar\u0131","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119536_bib17","doi-asserted-by":"crossref","DOI":"10.1895\/wormbook.1.101.1","article-title":"Maintenance of C. elegans","author":"Stiernagle","year":"2006","journal-title":"Wormbook"},{"key":"10.1016\/j.biopha.2026.119536_bib18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.taap.2018.03.016","article-title":"elegans as a model in developmental neurotoxicology","volume":"354","author":"Ruszkiewicz","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119536_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-4-38","article-title":"What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?","volume":"4","author":"Teschendorf","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.biopha.2026.119536_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/intbio\/zyz017","article-title":"Studying Parkinson's disease using Caenorhabditis elegans models in microfluidic devices","volume":"11","author":"Youssef","year":"2019","journal-title":"Integr. Biol. (Camb.)"},{"key":"10.1016\/j.biopha.2026.119536_bib21","first-page":"17","article-title":"Modeling Parkinson's disease in C. elegans","volume":"8","author":"Cooper","year":"2018","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2026.119536_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2023.06.001","article-title":"Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability","volume":"359","author":"Lu","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119536_bib23","first-page":"1085","article-title":"Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale","volume":"1744-7593","author":"das Neves","year":"2011"},{"key":"10.1016\/j.biopha.2026.119536_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/nano12071214","article-title":"Engineered nanoparticle-protein interactions influence protein structural integrity and biological significance","volume":"12","author":"Jaiswal","year":"2022","journal-title":"Nanomaterials"},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.119536_bib25","article-title":"Understanding protein-nanoparticle interactions leading to protein corona formation: in vitro - in vivo correlation study","volume":"256","author":"Marques","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119536_bib26","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","article-title":"Structure and fate of nanoparticles designed for the nasal delivery of poorly soluble drugs","volume":"18","author":"Clementino","year":"2021","journal-title":"Mol. Pharm."},{"issue":"46","key":"10.1016\/j.biopha.2026.119536_bib27","doi-asserted-by":"crossref","first-page":"39557","DOI":"10.1021\/acsami.8b17224","article-title":"PEGylated PLGA nanoparticles as a smart carrier to increase the cellular uptake of a coumarin-based monoamine oxidase B inhibitor","volume":"10","author":"Fernandes","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"12","key":"10.1016\/j.biopha.2026.119536_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biom12121739","article-title":"Increasing cellular uptake and permeation of curcumin using a novel polymer-surfactant formulation","volume":"12","author":"Liu","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.biopha.2026.119536_bib29","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/pharmaceutics14091977","article-title":"Vitamin E TPGS-poloxamer nanoparticles entrapping a novel PI3K\u03b1 inhibitor potentiate its activity against breast cancer cell lines","volume":"14","author":"Sunoqrot","year":"2022","journal-title":"Pharmaceutics"},{"issue":"17","key":"10.1016\/j.biopha.2026.119536_bib30","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1021\/acsami.4c00614","article-title":"Rescuing a troubled tolcapone with PEGylated PLGA nanoparticles: design, characterization, and hepatotoxicity evaluation","volume":"16","author":"Pinto","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2026.119536_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080367","article-title":"Improved in vitro model for intranasal mucosal drug delivery: primary olfactory and respiratory epithelial cells compared with the permanent nasal cell line RPMI 2650. LID - 10.3390\/pharmaceutics11080367 [doi] LID - 367","volume":"11","author":"Ladel","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119536_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"29","key":"10.1016\/j.biopha.2026.119536_bib33","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"Saha","year":"2009","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119536_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/pharmaceutics11070331","article-title":"Boosting drug discovery for Parkinson\u2019s: enhancement of the delivery of a monoamine oxidase-B inhibitor by brain-targeted PEGylated polycaprolactone-based nanoparticles","volume":"11","author":"Pinto","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119536_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6009309","article-title":"Ribociclib nanostructured lipid carrier aimed for breast cancer: formulation optimization, attenuating in vitro specification, and in vivo scrutinization","volume":"2022","author":"Sartaj","year":"2022","journal-title":"BioMed. Res. Int."},{"issue":"17","key":"10.1016\/j.biopha.2026.119536_bib36","doi-asserted-by":"crossref","first-page":"21522","DOI":"10.1021\/acsami.4c00614","article-title":"Rescuing a troubled tolcapone with PEGylated PLGA nanoparticles: design, characterization, and hepatotoxicity evaluation","volume":"16","author":"Pinto","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"45","key":"10.1016\/j.biopha.2026.119536_bib37","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1002\/chem.201701384","article-title":"An optimized two-photon fluorescent probe for biological sensing and imaging of catechol-o-methyltransferase","volume":"23","author":"Wang","year":"2017","journal-title":"Chemistry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600572X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600572X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:51:37Z","timestamp":1787439097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600572X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"alternative-id":["S075333222600572X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119536","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119536"}}